1y return+31.6%S&P 500 +20.9%
3y return+35.0%S&P 500 +68.5%
5y return+12.6%S&P 500 +74.5%
10y return+144.1%S&P 500 +256.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since June 30, 2016: $244 against $357 in the S&P 500.2
Bellevue Group AGS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| AMGNAmgen Inc | $308.4M | 6.5% | +188.3% |
| VRTXVertex Pharmaceuticals Inc | $287.4M | 6.0% | −15.1% |
| ARGXArgenx Se | $279.3M | 5.9% | −3.8% |
| GILDGilead Sciences Inc | $272.7M | 5.7% | +84.5% |
| RVMDRevolution Medicines Inc | $196.3M | 4.1% | −32.1% |
| ORKAOruka Therapeutics Inc | $157.7M | 3.3% | +226.9% |
| INSMInsmed Inc | $148.6M | 3.1% | +13787.0% |
| SRRKScholar Rock Hldg Corp | $134.7M | 2.8% | −31.7% |
| Nuvalent IncCUSIP 670703107 | $130.1M | 2.7% | |
| VRDNViridian Therapeutics Inc | $123.7M | 2.6% | |
| RLAYRelay Therapeutics Inc | $115.7M | 2.4% | −20.6% |
| PCVXVaxcyte Inc | $114.6M | 2.4% | +65.6% |
| UTHRUnited Therapeutics Corp Del | $102.1M | 2.1% | +8976.3% |
| ISRGIntuitive Surgical Inc | $101.3M | 2.1% | −11.1% |
| REGNRegeneron Pharmaceuticals | $98.1M | 2.1% | −43.6% |
| Crinetics Pharmaceuticals InCUSIP 22663K107 | $98.0M | 2.1% | −20.1% |
| BBIOBridgebio Pharma Inc | $88.6M | 1.9% | +4587.3% |
| IMCRImmunocore Hldgs PLC | $88.5M | 1.9% | |
| ABTAbbott Laboratories | $85.9M | 1.8% | −17.8% |
| SYKStryker Corporation | $84.5M | 1.8% | +23.6% |
| Medtronic PLCCUSIP G5960L103 | $77.8M | 1.6% | +3.9% |
| IONSIonis Pharmaceuticals Inc | $77.1M | 1.6% | −46.5% |
| ELVNEnliven Therapeutics Inc | $75.6M | 1.6% | −35.8% |
| VERAVera Therapeutics Inc | $73.4M | 1.5% | |
| JBIOJade Biosciences Inc | $67.9M | 1.4% | −12.7% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| KRYSKrystal Biotech Inc | December 31, 2021 | +431.4% | $28.8M |
| RVMDRevolution Medicines Inc | December 31, 2020 | +373.0% | $196.3M |
| BBIOBridgebio Pharma Inc | March 31, 2023 | +349.2% | $88.6M |
| ARGXArgenx Se | June 30, 2020 | +311.9% | $279.3M |
| INSMInsmed Inc | June 30, 2020 | +287.2% | $148.6M |
| LLYEli Lilly & Co | June 30, 2022 | +270.0% | $35.8M |
| ISRGIntuitive Surgical Inc | June 30, 2020 | +109.4% | $101.3M |
| ORKAOruka Therapeutics Inc | March 31, 2026 | +94.0% | $157.7M |
| SYKStryker Corporation | June 30, 2020 | +74.7% | $84.5M |
| VRTXVertex Pharmaceuticals Inc | June 30, 2020 | +71.1% | $287.4M |
Sold off last quarter
- EWTXEdgewise Therapeutics Inc was $48.1M
- INSPInspire Med Sys Inc was $5.1M
- PENPenumbra Inc was $4.0M
- RNAAtrium Therapeutics Inc was $3.5M
- Masimo CorpCUSIP 574795100 was $1.6M
- EQNREquinor Asa was $742K
- Exxon Mobil CorpCUSIP 30231G102 was $741K
- BPBp PLC was $735K
- SHELShell PLC was $729K
- CSCOCisco Sys Inc was $621K
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +12.3% | +14.8% |
| March 31, 2026 | −5.4% | −4.6% |
| December 31, 2025 | +11.7% | +2.4% |
| September 30, 2025 | +10.9% | +7.8% |
| June 30, 2025 | +4.1% | +10.5% |
| March 31, 2025 | −3.6% | −4.6% |
| December 31, 2024 | −6.6% | +2.1% |
| September 30, 2024 | +4.7% | +5.4% |
| June 30, 2024 | −0.5% | +4.0% |
| March 31, 2024 | +4.0% | +10.0% |
| December 31, 2023 | +11.2% | +11.2% |
| September 30, 2023 | −9.3% | −3.6% |
| June 30, 2023 | +4.9% | +8.3% |
| March 31, 2023 | −3.3% | +7.0% |
| December 31, 2022 | +8.4% | +7.1% |
| September 30, 2022 | +2.3% | −5.3% |
| June 30, 2022 | −14.3% | −16.5% |
| March 31, 2022 | −8.1% | −4.9% |
| December 31, 2021 | −3.9% | +10.7% |
| September 30, 2021 | −2.0% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Bellevue Group AG Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1674546&type=13F-HR&dateb=&owner=include&count=40CIK 1674546
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1674546/000110465926096739/Filed August 14, 2026 · accession 0001104659-26-096739